Stock Analysis on Net

KLA Corp. (NASDAQ:KLAC)

Cash Flow Statement 
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

KLA Corp., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net income 1,088,416 824,527 945,851 836,446 601,541 582,534 741,375 684,654 697,837 978,795 1,026,065 805,398 730,660 717,517 1,068,485 633,058 567,170 456,983 420,142 410,315 78,009 380,305 346,396 217,328 192,645 369,100 395,944
Impairment of goodwill and purchased intangible assets 239,100 70,474 219,000 749 9,156 5,962 (23) 865 10,760 256,649 100 2,481
Depreciation and amortization 98,091 103,922 95,823 101,001 99,263 99,063 102,403 104,813 104,854 103,508 101,938 100,848 92,127 85,545 84,824 84,647 84,365 84,257 80,066 78,937 81,990 88,534 98,588 127,886 73,445 15,806 16,087
Loss on extinguishment of debt 13,286 22,538
Unrealized foreign exchange (gain) loss and other 4,558 11,346 7,718 4,214 7,629 (34,346) 9,970 17,602 (16,531) (20,679) 1,783 31,862 (7,059) 6,089 15,639 (6,102) 5,231 (5,663) (12,907) 15,047 (5,950) (5,550) 10,313 (812) 73 895 3,895
Asset impairment charges 11,307
Disposal of non-controlling interest 8,270
Stock-based compensation expense 70,201 61,841 61,700 58,621 56,682 48,620 48,772 49,907 48,130 38,405 34,982 36,849 37,087 27,766 25,216 27,690 30,327 26,827 26,992 26,378 31,270 26,789 26,944 28,168 34,193 15,695 16,138
Net gain on sale of assets (161)
Gain on sale of business (29,687) (4,422)
Deferred income taxes (35,437) (68,976) (81,682) (30,634) 11,886 (65,158) (71,322) 23,567 (66,596) (98,890) (156,226) 53,474 (11,747) 56,742 (427,970) (4,787) (151) (24,540) (14,967) (93,110) (27,511)
Gain on fair value adjustment of marketable equity securities (26,719)
Settlement of treasury lock agreement 415 82,799 (21,518)
Accounts receivable 185,975 (394,604) (91,660) (221,958) 194,311 (160,265) 107,018 105,096 342,090 (440,647) (55,073) (192,055) 126,414 (264,331) (180,354) (102,021) 16,055 (190,189) 73,000 10,431 73,103 (126,682) (75,214) (53,565) (72,796) (55,869) 36,079
Inventories (112,283) 64,958 (59,326) (32,843) 28,359 (21,189) (138,419) (144,654) (211,216) (127,647) (265,530) (170,600) (156,513) (101,701) (138,189) (123,725) (34,169) (26,215) (85,991) (56,609) (11,640) (1,477) (5,091) 13,179 (1,893) (15,109) (55,738)
Other assets 14,309 (90,845) 152,641 (65,884) (111,233) (104,872) (7,520) (90,591) (60,973) (15,091) 45,637 (193,341) (25,972) (2,430) 4,673 (63,738) (20,700) (31,850) 20,070 18,124 (23,899) 3,558 (8,930) (62,180) (3,068) 34,978 (16,853)
Accounts payable (12,227) 67,080 (12,463) 24,177 (10,238) 2,692 8,345 (105,844) (119,606) 44,317 36,472 19,256 41,797 (1,289) 41,868 48,414 32,735 8,039 (9,822) 19,905 (12,904) 35,258 18,885 (3,832) (590) (2,440) (14,765)
Deferred system revenue (204,221) 195,357 (108,648) (8,613) 110,442 218,250 14,057 117,928 (1,765) 95,079 (60,492) 72,246 (4,734) 112,387 33,469 (40,899) 57,820 21,038 (82,633) 3,652 89,280 (30,412) (4,833) 51,754 32,105 (19,723) (79,810)
Deferred service revenue 5,820 22,927 35,863 74,096 54,288 68,821 5,901 52,672 5,332 42,630 (12,411) 48,502 47,748 28,556 4,912 35,769 11,507 2,215 (3,646) 15,205 10,691 1,220 (4,337) 31,549 (15,371) 12,211 (13,325)
Other liabilities (31,043) (186,957) 49,421 142,685 (203,841) (230,908) 63,160 143,965 289,299 87,761 313,375 123,991 (50,930) 145,947 325,262 4,037 (99,595) 240,179 101,002 (6,189) (125,591) 16,088 91,043 3,497 (75,149) (73,372) 93,753
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions (153,670) (322,084) (34,172) (88,340) 62,088 (227,471) 52,542 78,572 243,161 (313,598) 1,978 (292,001) (22,190) (82,861) 91,641 (242,163) (36,347) 23,217 11,980 4,519 (960) (102,447) 11,523 (19,598) (136,762) (119,324) (50,659)
Adjustments to reconcile net income to net cash provided by operating activities (16,257) 24,988 49,387 56,169 308,437 39,708 142,365 274,461 313,018 (290,505) (14,520) 13,831 88,218 93,281 (204,688) (167,434) 78,980 104,098 92,029 42,531 364,019 7,426 149,849 108,133 (29,051) (86,928) (14,539)
Net cash provided by operating activities 1,072,159 849,515 995,238 892,615 909,978 622,242 883,740 959,115 1,010,855 688,290 1,011,545 819,229 818,878 810,798 863,797 465,624 646,150 561,081 512,171 452,846 442,028 387,731 496,245 325,461 163,594 282,172 381,405
Acquisition of non-marketable securities (630)
Proceeds from sale of assets 161 5,079 27,658 741 1,114
Net proceeds from sale of business 75,358 16,833
Business acquisitions, net of cash acquired (3,682) (27,144) (8,226) (432,901) (37,986) (11,543) (70) (78,530) (1,806,496) (11,787)
Acquisition of intellectual property (2,850)
Capital expenditures (82,135) (92,323) (60,393) (60,745) (71,793) (76,801) (68,045) (78,683) (84,914) (93,642) (84,352) (73,160) (100,304) (64,901) (68,955) (55,376) (61,183) (59,144) (55,925) (41,790) (43,445) (34,874) (32,566) (55,846) (25,956) (26,366) (22,330)
Proceeds from capital-related government assistance 315
Purchases of available-for-sale and equity securities (697,596) (489,033) (837,935) (602,081) (1,172,264) (451,800) (530,842) (481,096) (402,672) (301,372) (256,793) (254,274) (207,546) (261,840) (264,000) (223,620) (303,076) (260,227) (231,821) (233,838) (156,173) (144,715) (263,767) (78,847) (2,686)
Proceeds from sale of available-for-sale securities 93,085 183,097 55,322 36,816 55,722 7,252 7,983 50,079 37,786 10,147 26,608 46,033 26,713 25,838 14,954 19,759 14,962 57,563 53,249 44,199 69,034 10,287 25,449 16,867 40,920 107,370 91,238
Proceeds from maturity of available-for-sale securities 378,471 1,010,660 671,925 488,779 342,808 427,128 201,149 434,819 345,972 141,926 211,465 235,871 151,724 194,539 178,414 163,232 159,120 163,492 95,835 135,674 133,819 158,699 198,751 146,217 60,298 128,052 254,757
Purchases of trading securities (53,418) (17,276) (17,581) (21,635) (46,456) (16,049) (49,958) (18,852) (40,176) (18,071) (19,512) (19,912) (43,000) (35,446) (22,896) (24,001) (48,495) (16,741) (18,630) (41,584) (46,784) (12,852) (9,021) (18,594) (30,328) (27,481) (4,619)
Proceeds from sale of trading securities 43,341 18,420 17,623 18,644 37,619 16,715 48,042 19,249 30,797 19,607 19,875 20,616 35,820 34,751 25,163 26,402 45,251 18,424 21,244 43,061 45,407 15,307 11,905 20,642 27,289 29,722 7,612
Proceeds from other investments 984 1,430 1,020 795 614 1,086
Net cash (used in) provided by investing activities (319,803) 613,706 (171,039) (138,792) (858,046) (88,476) (391,671) (74,484) (113,207) (241,405) (53,475) (25,394) (569,494) (106,264) (175,306) (93,604) (176,588) (95,892) (134,320) (105,821) 1,788 (8,148) (146,693) 30,439 (1,734,903) 208,611 314,871
Payment of debt issuance costs (6,515)
Proceeds from issuance of debt, net of issuance costs 735,043 2,967,409 40,343 (172) 742,004 (2,478) 1,186,263
Proceeds from revolving credit facility 300,000 275,000 300,000 300,000 200,000 250,000 900,000
Repayment of debt (750,000) (225,000) (200,000) (662,250) (275,000) (45,000) (300,000) (20,000) (50,000) (175,000) (721,033) (275,000) (902,474)
Common stock repurchases (506,745) (650,121) (567,383) (470,266) (372,251) (437,817) (455,412) (388,825) (478,186) (355,007) (89,846) (2,573,589) (564,666) (429,874) (399,677) (299,777) (273,441) (177,492) (187,897) (315,995) (284,593) (228,496) (344,986) (200,029) (250,213) (299,974)
Forward contract for accelerated share repurchases (900,000)
Payment of dividends to stockholders (225,774) (226,776) (198,079) (197,521) (197,154) (196,859) (181,507) (179,510) (180,854) (184,208) (187,984) (157,602) (158,976) (159,129) (162,821) (139,267) (139,338) (139,584) (141,164) (132,762) (133,327) (134,696) (121,636) (121,363) (113,581) (114,562) (122,757)
Payment of dividends to subsidiary’s non-controlling interest holders (602) (1,239)
Issuance of common stock 47,538 96,501 48,433 90,939 33,793 115 76,102 36,912 59,742 26,356 50,349 672 24,499 114 44,272 20,556
Tax withholding payments related to vested and released restricted stock units (2,680) (3,608) (72,246) (47,508) (24,274) (3,005) (68,237) (21,102) (16,154) (2,598) (54,952) (15,423) (16,661) (5,755) (46,532) (13,543) (6,674) (11,000) (25,145) (5,527) (4,958) (12,237) (23,538) (6,942) (381) (3,233) (26,961)
Contingent consideration payable and other, net (67) (2,440) (1,676) (12,823) (2,527) (2,500) (21) (1,100) 2,996 (3) (57) (649) (513)
Purchase of non-controlling interest (4,295)
Net cash provided by (used in) financing activities (735,199) (1,582,967) (837,708) (618,861) 138,924 (590,924) (705,156) (511,321) (902,721) (710,520) (705,727) (603,726) (486,403) (557,846) (609,030) (392,845) (439,453) (261,377) (404,206) (61,355) (432,637) (432,030) (373,613) (432,146) 869,285 (347,452) (449,692)
Effect of exchange rate changes on cash and cash equivalents 2,587 (19,178) 13,582 (6,000) (7,743) 10,642 (3,208) (13,958) 2,109 15,832 (17,971) (20,373) (4,866) 805 (4,507) 3,285 (9,425) 11,834 7,766 2,564 (4,868) 3,963 (3,585) 77 205 1,137 (1,452)
Net increase (decrease) in cash and cash equivalents 19,744 (138,924) 73 128,962 183,113 (46,516) (216,295) 359,352 (2,964) (247,803) 234,372 169,736 (241,885) 147,493 74,954 (17,540) 20,684 215,646 (18,589) 288,234 6,311 (48,484) (27,646) (76,169) (701,819) 144,468 245,132

Based on: 10-Q (reporting date: 2025-03-31), 10-Q (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-K (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-K (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-K (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-K (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30).


Net Income
Net income exhibits significant volatility over the periods, with notable peaks in early 2021 and mid-2022, reaching over one million thousand USD. After a sharp decline in early 2020, net income recovered strongly and demonstrated an overall upward trajectory towards 2024, reflecting improved profitability despite some periodic dips.
Impairment Charges
Impairment of goodwill and intangible assets occurred sporadically, with a particularly large charge in early 2020 and substantial amounts again in late 2022 and 2024, indicating intermittent write-downs affecting earnings in these periods. Asset impairment charges appear isolated and minimal.
Depreciation and Amortization
This expense consistently increased over time, rising from approximately 16,000 thousand USD in 2018 to above 100,000 thousand USD by 2024, suggesting growing capital asset base or changes in amortization policies.
Loss on Extinguishment of Debt
Losses related to debt extinguishment were concentrated in mid-2020 and early 2022 periods, indicating refinancing or early repayment activities incurring costs.
Unrealized Foreign Exchange Gains and Losses
Foreign exchange effects displayed high volatility, alternating between significant gains and losses across quarters, reflecting exposure to currency fluctuations and associated risks.
Stock-Based Compensation Expense
This expense consistently increased from about 16,000 thousand USD in 2018 to over 70,000 thousand USD by 2025, indicating expanded employee incentive costs or greater share-based compensation over time.
Deferred Income Taxes
Deferred income taxes fluctuated greatly, with large negative amounts in early 2021 and intermittent positive spikes, suggesting complex tax timing differences and possibly adjustments related to tax positions or asset valuations.
Accounts Receivable
Accounts receivable balances displayed extreme swings, with substantial positive and negative changes indicating variability in sales collections or possible reclassifications.
Inventories
Inventory levels experienced considerable volatility, initially showing negative changes but turning positive in late 2023 and fluctuating thereafter, which may reflect inventory management challenges or changes in demand.
Accounts Payable
Accounts payable changes were inconsistent, alternating between increased payables and repayments, with notable negative balances in late 2022 and 2023, possibly indicating timing of supplier payments.
Deferred Revenues (System and Service)
Deferred system revenue and deferred service revenue showed irregular patterns with substantial positive and negative variances, suggesting fluctuations in advance payments or revenue recognition timing.
Other Liabilities
Other liabilities shifted markedly with large increases in some quarters followed by reductions, indicating dynamic changes in other obligations or accruals.
Net Cash Provided by Operating Activities
Operating cash flow generally increased over time, peaking above one billion thousand USD in various 2022 and 2024 periods, reflecting strong cash-generating ability despite some quarter-to-quarter variations.
Investing Activities
Cash flows from investing activities were highly variable, with episodes of large outflows, especially relating to acquisitions and capital expenditures. The purchase of securities consistently consumed cash, while sales and maturities provided inflows. Capital expenditures total amounts increased from approximately 22,000 thousand USD to over 90,000 thousand USD quarterly, indicating significant ongoing investments.
Financing Activities
Financing cash flows were predominantly outflows related to debt repayments, common stock repurchases, and dividend payments. Notably, stock buybacks increased substantially, reaching multi-hundred million USD levels in some quarters. Debt issuances and repayments were irregular, with large debt issuance spikes offset by repayments in subsequent periods.
Dividends and Stock Repurchases
Dividend payments increased steadily over time, consistently reaching above 180,000 thousand USD per quarter by 2023-2024, demonstrating a commitment to returning capital to shareholders. Stock repurchases showed an increasing trend with intermittent acceleration programs, indicating active capital return strategies.
Overall Liquidity and Cash Position
Cash and cash equivalents fluctuated significantly, with net increases and decreases alternating, but generally supported by strong operating cash flow and financing activities. Currency effects added further volatility to cash balances.